AbbVie
ABBV
#28
Rank
$289.42 B
Marketcap
$163.66
Share price
1.26%
Change (1 day)
40.04%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2022 (TTM): $14.78 B

According to AbbVie's latest financial reports the company's current earnings (TTM) are $14.78 B. In 2021 the company made an earning of $12.98 B an increase over its 2020 earnings that were of $3.39 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2022

Annual earnings

Year Earnings Change
2022 (TTM)$14.78 B13.81%
2021$12.98 B282.25%
2020$3.39 B-59.67%
2019$8.42 B62.13%
2018$5.19 B-32.74%
2017$7.72 B-1.99%
2016$7.88 B18.65%
2015$6.64 B180.5%
2014$2.36 B-55.57%
2013$5.33 B-6.86%
2012$5.72 B56.05%
2011$3.66 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$34.92 B 136.24%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.54 B-55.69%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.72 B-47.72%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.39 B-77.05%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.54 B-69.28%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.71 B-47.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.38 B-83.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
$6.58 B-55.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
$94.8 M-99.36%๐Ÿ‡บ๐Ÿ‡ธ USA